Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, but concerns about tirzepatide and thyroid nodules have emerged from animal studies showing thyroid C-cell tumors in rodents
The primary active ingredient is the same
Similarly, oxidative stress states such as sepsis and critical illness can predispose to pyroglutamate accumulation due to increased GSH demand driven by elevated reactive oxygen species production [65]
Glutathione can improve digestion, including the symptoms of leaky gut syndrome
Khizer Sohail Sheikh: Data curation, Writing original draft, Writing review & editing, Visualization
It is important to understand that weight gain is not a listed adverse reaction in the UK Summary of Product Characteristics (SmPC)